|
Brachytherapy with the TheraSeed® device involves a simple, one-time
procedure. Typically, a patient receives local anesthesia and does not feel
anything below the waist. Often, medication is used to induce relaxation and
drowsiness. Using ultrasound equipment to see inside the body, the physician
inserts thin, hollow needles into the prostate gland and deposits about 75 to
150 tiny seeds. The procedure lasts approximately 45 minutes and is usually
performed in an outpatient setting. Most patients leave the hospital within
hours and resume routine activities in about two to three days. That’s it.
While it’s based on hard science and years of independent clinical research,
you experience only a few hours of inconvenience.
During the next few months, the radioactive ingredient, palladium-103 (Pd-103),
fights cancer from inside the body. It delivers a highly concentrated, yet
confined dose of radiation directly to surrounding cells, minimizing exposure
to nearby healthy tissue and organs. The seeds remain in place permanently and
are compatible with body tissues.
Patients undergoing brachytherapy may experience the following side effects:
| • |
The most commonly reported side effects are short-term urinary or obstructive
symptoms within the first few weeks after the implant procedure.
|
| • |
Short-term side effects include frequent urination and burning. |
| • |
Rectal irritation and bleeding may occur. |
| • |
Tenderness and bruising may occur from the procedure, rarely requiring pain
medication.
|
In addition to brachytherapy, some physicians may recommend combining TheraSeed®
treatment with hormone therapy and/or external beam radiation therapy.
|